How do we help lung cancer patients?
We review your case and provide a list of options from available lung cancer clinical trials close to your home as part of Massive Bio SYNERGY-AI program or Massive Bio Virtual Tumor Board solution.
We can provide a second opinion through our Virtual Tumor Board from a lung cancer specialist. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.
There are approximately 737 lung cancer clinical trials that are currently recruiting patients in the United States right now With such an extensive list, many of them could be beneficial for you. Our team of oncology nurses and our artificial intelligence based clinical trial matching system will find the best option for you.
REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer
Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600E-mutant Non-small Cell Lung Cancer
Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations
Lung Cancer Facts
Lung cancer is known to be one of the most deadly types of cancer. Only 18.6% of lung cancer patients survive five years. Not only one of the hardest types of cancer to treat, but also the most popular. There are 2.1 million new cases worldwide and 1.8 million deaths annually.
The two subtypes are small cell and non-small cell lung cancer. Non-small cell accounts for 85% of all lung cancer patients and small cell accounts for 15%. The main difference between the two subtypes is the size of the cancer cells.
95% of small cell lung cancer patients have a history of smoking.
The biggest contributor and most well known risk factor for lung cancer is smoking. Smoking cigarettes and being exposed to smoke (Secondhand Smoke) directly lead to lung cancer. Other risk factors include being exposed to radiation, asbestos, tar, air pollution, and any other toxin that is commonly known to be harmful.
- Radiation therapy
- Targeted therapy
- Laser therapy
- Photodynamic therapy (PDT)
- Watching & Waiting
Learn Your Lung Cancer Clinical Trial and Treatment Options
Low-dose CT scans are the most common form of screening for lung cancer. Using small amounts of radiation, the scans are used to detect cancer as small as a grain of rice. X-rays used to be the primary form of screening but they can only detect cancer the size of a dime.
Lung cancer is the leading cause of death by cancer for men and women. Despite being responsible for the most cancer deaths, it is only the 4th most popular cancer type. For cases discovered before the cancer has metastasized, the 5-year survival rate is 56%. If the cancer has already spread, the 5-year survival rate is only 5%. These numbers are discouraging when only 16% of lung cancer cases are discovered at an early stage.
- Non-Small Cell Lung Cancer: Squamous cell carcinoma (epidermoid carcinoma), Large cell carcinoma, Adenocarcinoma
- Small Cell Lung Cancer: Small cell carcinoma (oat cell cancer) and combined small cell carcinoma.
Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.